MedTrace Logo

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

NCT04798976 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-03-16

No results posted yet for this study

Summary

A population-based case-cohort study of breast cancer-specific survival among all first invasive breast cancer cases

Conditions

  • Breast Cancer-specific Survival

Interventions

DRUG

neoadjuvant/adjuvant therapy

chemotherapy/endocrine therapy/surgery/radiotherapy

Sponsors & Collaborators

  • Center for New Medical Technologies, Novosibirsk, Russia

    collaborator OTHER

  • I.M. Sechenov First Moscow State Medical University

    collaborator OTHER

  • Center of Personalized Medicine, Pirogova

    lead OTHER

Eligibility

Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-05-01
Completion
2021-05-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04798976 on ClinicalTrials.gov